Free Newsletter
Indian pharma exports drop 40% in downturn
The economic downturn in the U.S. has hurt the pharmaceuticals industry worse than any other export sector in the Indian economy. Drug exports dropped almost 40 percent between October 2008 and the end of February 2009 as Indian companies lose relative share to other emerging-market competitors. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: